Sangamo Therapeutics (SGMO)
(Delayed Data from NSDQ)
$0.67 USD
+0.05 (7.28%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $0.67 0.00 (-0.03%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.22 | 0.00% |
Earnings Summary
For their last quarter, Sangamo Therapeutics (SGMO) reported earnings of -$0.34 per share, missing the Zacks Consensus Estimate of -$0.25 per share. This reflects a negative earnings surprise of 36.00%. Look out for SGMO's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.22 per share, reflecting a year-over-year decrease of 283.33%.
Earnings History
Price & Consensus
Zacks News for SGMO
Sangamo Therapeutics (SGMO) Reports Q2 Loss, Misses Revenue Estimates
SGMO: What are Zacks experts saying now?
Zacks Private Portfolio Services